{"Ticker": "SYK", "Company": "Stryker Corporation", "Sector": "Health Care", "Updated": "2021-12-10", "Rating": [{"Date": "2021-12-10", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$278"}, {"Date": "2021-12-07", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$305"}, {"Date": "2021-09-14", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2021-07-28", "Rating": "Upgrade", "Organization": "Northland Capital", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$248 to $310"}, {"Date": "2021-06-01", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$260 to $285"}, {"Date": "2021-05-25", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$280"}, {"Date": "2020-10-06", "Rating": "Initiated", "Organization": "Northland Capital", "Rating_Change": "Market Perform", "Target_Change": "$225"}, {"Date": "2020-09-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform", "Target_Change": "$230"}, {"Date": "2020-04-13", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$155"}, {"Date": "2020-04-01", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Sell", "Target_Change": "$248 to $150"}, {"Date": "2020-03-05", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$235"}, {"Date": "2020-02-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$248"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "SunTrust", "Rating_Change": "Hold", "Target_Change": "$217"}, {"Date": "2020-01-07", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$210"}, {"Date": "2020-01-07", "Rating": "Downgrade", "Organization": "Piper Jaffray", "Rating_Change": "Overweight to Neutral", "Target_Change": "$210"}, {"Date": "2019-12-30", "Rating": "Reiterated", "Organization": "BTIG Research", "Rating_Change": "Buy", "Target_Change": "$228 to $236"}, {"Date": "2019-11-05", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Overweight to Equal Weight", "Target_Change": "$226 to $207"}, {"Date": "2019-10-30", "Rating": "Reiterated", "Organization": "BofA/Merrill", "Rating_Change": "Buy", "Target_Change": "$220 to $245"}, {"Date": "2019-07-02", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}, {"Date": "2019-01-30", "Rating": "Reiterated", "Organization": "Canaccord Genuity", "Rating_Change": "Buy", "Target_Change": "$185 to $190"}]}